Contact Us | Print Page | Sign In | Register
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

New from our Partners
Friday, October 12, 2018
New from our Partners: Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, »
Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, Evobrutinib in RMS   Fir...
Wednesday, October 10, 2018
News from our Partners: Novartis announces FDA filing acceptance of siponimod (BAF312) »
Novartis announces FDA filing acceptance of siponimod (BAF312), the first and only oral drug shown to delay disability pro...
Wednesday, October 10, 2018
News from our Partners: Press Release - New Efficacy and Safety Data on MS Portfolio to be Presented »
New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018   Late-breaking Phase I...
Wednesday, October 10, 2018
News from our Partners: Press Release - Ocrevus data show early initiation reduces progression »
PRESS RELEASE: OCREVUS (OCRELIZUMAB) DATA SHOW EARLY INITIATION OF TREATMENT REDUCES DISABILITY PROGRESSION OVER FIVE YEAR...
Wednesday, September 12, 2018   (0 Comments - view/add)
News from our Partners: Novartis announces PARADIGMS study demonstrating benefit of Gilenya┬« »
Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children...
Tuesday, July 3, 2018
News from our Partners: Temperament Can Play a Big Role in Quality of Life with MS »
Researchers say if a person with multiple sclerosis is irritable or anxious, it can make overcoming the obstacles of their...
Thursday, June 14, 2018
News from our Partners: PRESS RELEASE: GENENTECH ANNOUNCES NEW OCREVUS (OCRELIZUMAB) DATA FOR PPMS »
PRESS RELEASE: GENENTECH ANNOUNCES NEW OCREVUS (OCRELIZUMAB) DATA ON LONG-TERM DISABILITY BENEFITS IN PRIMARY PROGRESSIVE...
Tuesday, May 1, 2018   (0 Comments - view/add)
News from our Partners: AAN Publishes Guideline on Disease-modifying Therapies for MS »
The AAN published a new guideline, Practice Guideline: Disease-modifying Therapies for Adults with Multiple Sclerosis, in...
Tuesday, May 1, 2018
News from our Partners: TREAT-MS »
Dr. Scott Newsome and Dr. Ellen Mowry are pleased to announce the launch of their TREAT-MS trial at Hopkins. They will be...

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org